CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria
Summary
Austria is one of the largest healthcare markets, with a strong focus on pharmaceutical R&D. Austria was ranked sixth globally in terms of healthcare spending (11.1% of GDP). In 2016, the healthcare spending increased to 11.2% of the GDP and per capita spending was $5,227.The value of the Austrian pharmaceutical market value increased from €2.48 billion in 2010 to €2.87 billion in 2017, at a CAGR of 2%.
The aging population, rapid advances in new treatment options, robust healthcare system, high focus on R&D and change in demographics are expected to drive the growth of the pharmaceutical market. However, generic substitution and shortage of specialized staff act as a major barrier for the pharmaceutical market.
On the other hand, Austrian Medical Device market was valued at $1.63 billion in 2010 and increased to $1.95 billion in 2017.The main segments were nephrology and urology devices, orthopedic devices, ophthalmic devices, cardiovascular devices, and in vitro diagnostics. Medical device innovations to provide optimal, quick and affordable patient care in Austria are in the pipeline for years to come.
"CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria", report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Austria. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Austria. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Austria, and includes:
Reasons to buy
This report will enhance your decision-making capability by allowing you to:
Summary
Austria is one of the largest healthcare markets, with a strong focus on pharmaceutical R&D. Austria was ranked sixth globally in terms of healthcare spending (11.1% of GDP). In 2016, the healthcare spending increased to 11.2% of the GDP and per capita spending was $5,227.The value of the Austrian pharmaceutical market value increased from €2.48 billion in 2010 to €2.87 billion in 2017, at a CAGR of 2%.
The aging population, rapid advances in new treatment options, robust healthcare system, high focus on R&D and change in demographics are expected to drive the growth of the pharmaceutical market. However, generic substitution and shortage of specialized staff act as a major barrier for the pharmaceutical market.
On the other hand, Austrian Medical Device market was valued at $1.63 billion in 2010 and increased to $1.95 billion in 2017.The main segments were nephrology and urology devices, orthopedic devices, ophthalmic devices, cardiovascular devices, and in vitro diagnostics. Medical device innovations to provide optimal, quick and affordable patient care in Austria are in the pipeline for years to come.
"CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria", report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Austria. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Austria. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Austria, and includes:
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Pfizer, Merck, Sanofi and Gerot Lannach) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, Roche, DePuy and Sanochemia Pharmazeutika)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Austria
- Porter’s five forces analysis for pharmaceutical and medical devices market of Austria
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Austrian healthcare market.
Reasons to buy
This report will enhance your decision-making capability by allowing you to:
- Develop business strategies by understanding the trends shaping and driving the Austrian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Austrian healthcare market.
Table of Contents
- Executive Summary
- Overview of Pharmaceutical Market
- Overview of Medical Device Market
- Deals Analysis
- Porter’s Five Forces Model
- Market Access
- Country Healthcare Landscape
- Opportunities and Challenges
- Appendix
List of Tables
Table 1: Pharmaceutical Market, Austria, Sales of Patented Drug Products by Major Therapeutic Class ($m), 2016
Table 2: Medical Device Market, Austria, Revenue by Segment
Table 3: Nephrology and Urology Devices Market, Austria, Revenue and Market Share of Major Players
Table 4: Orthopedic Market, Austria, Revenue and Market Share of Major Players
Table 5: Ophthalmic Devices Market, Austria, Revenue and Market Share of Major Players
Table 6: Cardiovascular Devices, Austria, Revenue and Market Share of Major Players
Table 7: InVitro Diagnostics Devices Market, Austria, Revenue and Market Share of Major Players
Table 8: Market Authorization Fees, 2017, Austria
Table 9: Patent Fees, 2017, Austria
Table 10: Criteria for New Pharmacy Establishment, Austria
Table 11: Label of a Pharmaceutical Product, Austria, 2017
Table 12: Trade Associations, Austria
Table 13: Trade Fairs, Austria
List of Figures
Figure 1: Pharmaceutical Market, Austria, Revenue, 2009-2016
Figure 2: Medical Device Market, Austria, Revenue, 2009-2016
Figure 3: Generics Market Share (by value), Austria, Sales (%), 2015
Figure 4: Number of Deals (2017-2018)
Figure 5: 2017-2018 Deal Overview By Region
Figure 6: Country Profile, Austria, 2017
Figure 7: Pharmaceutical Market, Austria, Revenue, 2010-2017
Figure 8: Pharmaceutical Market, Austria, Revenue Forecast, 2018-2022
Figure 9: Pharmaceutical Market, Austria, Pharmaceutical Exports
Figure 10: Pharmaceutical Market, Austria, Top Export Partners
Figure 11: Pharmaceutical Market, Austria, Pharmaceutical Imports
Figure 12: Pharmaceutical Market, Austria, Top Import Partners
Figure 13: Pharmaceutical Market, Austria, Supply Channels
Figure 14: Pharmaceutical Market, Austria, Sales of Patented Drug Products by Major Therapeutic Class, 2016
Figure 15: Pharmaceutical Market, Austria, Major Players
Figure 16: Medical Device Market, Austria, Revenue
Figure 17: Medical Device Market, Austria, Revenue Forecast
Figure 18: Medical Device Market, Austria, Revenue by Segment
Figure 19: Nephrology and Urology Devices Market, Austria, Revenue
Figure 20: Nephrology and Urology Devices Market, Austria, Market Share of Major Players
Figure 21: Orthopedic Devices Market, Austria, Revenue
Figure 22: Orthopedic Devices Market, Austria, Market Share of Major Players
Figure 23: Ophthalmic Devices Market, Austria, Revenue
Figure 24: Ophthalmic Devices Market, Austria, Market Share of Major Players
Figure 25: Cardiovascular Market, Austria, Revenue
Figure 26: Cardiovascular Market, Austria, Market Share of Major Players
Figure 27: InVitro Diagnostics Market, Austria, Revenue
Figure 28: InVitro Diagnostics Market, Austria, Market Share of Major Players
Figure 29: Medical Device Market, Austria, Revenue of Major Players
Figure 30: Deal Value and Deal Count, Pharmaceutical Market, Austria, 2017-2018
Figure 31: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Austria, 2017-2018
Figure 32: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Austria, 2017-2018
Figure 33: Top Five Therapy Area by Deal Value, Pharmaceutical Market, Austria, 2017-2018
Figure 34: Top Five Therapy Area by Deal number, Pharmaceutical Market, Austria, 2017-2018
Figure 35: M&A Deals by Therapy Area, Pharmaceutical Market, Austria, 2017-2018 (by value and by number)
Figure 36: Venture Financing Deals by Therapy Area, Pharmaceutical Market, Austria, 2017-2018 (by value and by number)
Figure 37: Private Equity Deals by Therapy Area, Pharmaceutical Market, Austria, 2017-2018 (by value and by number)
Figure 38: Medical Device Market Deals, Austria, 2017-2018 (by deal value, $m)
Figure 39: Medical Device Market Deals, Austria, 2017- 2018 (by deal count)
Figure 40: Medical Device Market Deals Share (by deal count), Austria, 2017-2018
Figure 41: Medical Device Market Deals Share (by deal value), Austria, 2017-2018
Figure 42: Top Therapy Area by Deal Value, Medical Device, Austria, 2017-2018
Figure 43: Top Therapy Area by Deal Number, Medical Device, Austria, 2017-2018
Figure 44: M&A Deals by Therapy Area, Medical Device, Austria, 2017-2018 (by value and by number)
Figure 45: Venture Financing Deals by Therapy Area, Medical Device, Austria, 2017-2018 (by value and by number)
Figure 46: Private Equity Deals by Therapy Area, Medical Device Austria, 2017-2018 (by value and by number)
Figure 47: Healthcare System, Austria
Figure 48: Drug Funding and Reimbursement Approval Process, Austria
Figure 49: Austrian Social Security System, Austria
Figure 50: Services of Social Health Insurance, Austria
Figure 51: Out-of-Pocket Expenditure (% of total expenditure on health)
Figure 52: Pharmaceutical and Consumer Price Index
Figure 53: Federal Ministry of Health, Organization Chart, Austria
Figure 54: Centralized Procedure, 2017, Austria
Figure 55: Decentralized Procedure, 2017, Austria
Figure 56: Decentralized Procedure, 2017, Austria
Figure 57: Mutual Recognition Procedure, 2017, Austria
Figure 58: Conformity Assessment of Class I Medical Devices, EU, 2017
Figure 59: Conformity Assessment of Class IIa Medical Devices, EU, 2017
Figure 60: Conformity Assessment of Class IIb Medical Devices, EU, 2017
Figure 61: Conformity Assessment of Class III Medical Devices, EU, 2017
Figure 62: European Patent Approval Process, EU, 2017
Figure 63: Unitary Patent Approval Process, EU, 2017
Figure 64: Trademark Approval Process, Austria, 2018
Figure 65: Clinical Trial Process, Austria, 2017
Figure 66: Number of Hospitals, Austria, 2010-2017
Figure 67: Diagnostic Equipment, Austria, 2010-2017
Figure 68: Hospital Beds (per 1,000 population), Austria
Figure 69: Acute Care Hospital Beds (per 1,000 population), Austria
Figure 70: Psychiatric Hospital Beds (per 1,000 population), Austria
Figure 71: Life Expectancy, 2010-2017, Austria
Figure 72: Immunization Rate (%), 2010-2017, Austria
Figure 73: PM2.5 (µg per m3), Austria, 2010-2016
Figure 74: CO2 Emissions (million tons), Austria, 2010-2016
Figure 75: Physicians (per 1,000 population), Austria, 2010-2016
Figure 76: Nurses (per 1,000 population), Austria, 2010-2016
Figure 77: Dentists (per 1,000 population), Austria, 2010-2016
Figure 78: Pharmacists (per 1,000 population), Austria, 2010-2016
Figure 79: Major Causes of Mortality (per 100,000 population), Austria, 2015
Figure 80: Major Causes of Male Mortality, Austria, 2015
Figure 81: Major Causes of Female Mortality, Austria, 2015
Figure 82: Disability-Adjusted Life Years by Major Disease (‘000), Austria, 2016
Figure 83: Healthcare Expenditure as Percentage of GDP (%), Austria, 2010-2017
Figure 84: Public-Private Share (%), Austria, 2010-2016
Figure 85: Major Components of Healthcare Spending (%), Austria, 2016
Figure 86: Opportunities and Challenges, Austria
